Pacira announces layoffs due to efficiencies in Exparel production

cagkansayin/iStock via Getty Images

Pacira BioSciences (NASDAQ:PCRX) announced plans to lay off 71 employees, nearly 8% of its total workforce, on Thursday, attributing the decision to enhanced manufacturing efficiencies related to its pain therapy Exparel.

The Tampa, Florida-based biopharma said that the commissioning of two